pentadecanoic acid has been researched along with Dyslipidemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukuda, S; Hara, H; Hayashi, T; Jayaratne, K; Jayatilleke, AU; Kajio, H; Karunapema, P; Kurotani, K; Mizoue, T; Noda, M; Nonaka, D; Okazaki, O; Sato, M | 1 |
| Adeli, K; Baker, C; Bradshaw, CD; Brant, AF; Cramer, CT; Filippov, S; Hanselman, JC; Houghton, JL; Hurley, TR; Naples, M; Newton, RS; Pinkosky, SL; Spahr, MA; Srivastava, RA | 1 |
2 other study(ies) available for pentadecanoic acid and Dyslipidemia
| Article | Year |
|---|---|
Circulating odd-chain saturated fatty acids were associated with arteriosclerosis among patients with diabetes, dyslipidemia, or hypertension in Sri Lanka but not Japan.
Topics: Aged; Arteriosclerosis; Asian People; Diabetes Mellitus; Diet; Dietary Fats; Dyslipidemias; Fatty Acids; Fatty Acids, Omega-3; Fatty Acids, Omega-6; Female; Humans; Hypertension; Japan; Male; Middle Aged; Sri Lanka; Vascular Stiffness | 2018 |
AMP-activated protein kinase and ATP-citrate lyase are two distinct molecular targets for ETC-1002, a novel small molecule regulator of lipid and carbohydrate metabolism.
Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Animals; ATP Citrate (pro-S)-Lyase; Biomarkers; Calcium; Carbohydrate Metabolism; Cricetinae; Dicarboxylic Acids; Diet; Dyslipidemias; Energy Metabolism; Enzyme Activation; Enzyme Inhibitors; Fatty Acids; Female; Glucagon; Glucose; Hep G2 Cells; Humans; Lipid Metabolism; Liver; Male; Mice; Molecular Targeted Therapy; Obesity; Protein Serine-Threonine Kinases; Rats; Signal Transduction; Sterols | 2013 |